Published in Am J Gastroenterol on July 01, 2002
High resolution impedance manometric findings in dysphagia of Huntington's disease. World J Gastroenterol (2012) 0.92
Noncardiac chest pain: current treatment. Gastroenterol Hepatol (N Y) (2007) 0.87
Ineffective oesophageal motility: manometric subsets exhibit different symptom profiles. World J Gastroenterol (2008) 0.85
Oesophageal motor functions and its disorders. Gut (2004) 0.84
Treatment of esophageal (noncardiac) chest pain: an expert review. Clin Gastroenterol Hepatol (2013) 0.83
Treatment of Epiphrenic and Mid-esophageal Diverticula. Curr Treat Options Gastroenterol (2004) 0.80
The use of botulinum toxin for the treatment of gastrointestinal motility disorders. Dig Dis Sci (2004) 0.80
Botulinum toxin and gastrointestinal tract disorders: panacea, placebo, or pathway to the future? Gastroenterol Hepatol (N Y) (2008) 0.79
Treatment of gastrointestinal sphincters spasms with botulinum toxin A. Toxins (Basel) (2015) 0.79
Therapeutic options in oesophageal dysphagia. Nat Rev Gastroenterol Hepatol (2015) 0.76
A Review of Esophageal Chest Pain. Gastroenterol Hepatol (N Y) (2015) 0.75
Management of esophageal chest pain. Gastroenterol Hepatol (N Y) (2007) 0.75
Functional aspects of distal oesophageal spasm: the role of onset velocity and contraction amplitude on bolus transit. Dig Liver Dis (2012) 0.75
Clinical guideline: management of gastroparesis. Am J Gastroenterol (2012) 3.86
Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol (2007) 3.65
American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology (2004) 2.98
Gastric electrical stimulation with Enterra therapy improves symptoms from diabetic gastroparesis in a prospective study. Clin Gastroenterol Hepatol (2010) 2.57
Use of serum prolactin in diagnosing epileptic seizures: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2005) 2.38
Cellular changes in diabetic and idiopathic gastroparesis. Gastroenterology (2011) 2.30
Characteristics of patients with chronic unexplained nausea and vomiting and normal gastric emptying. Clin Gastroenterol Hepatol (2011) 2.09
Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology (2006) 2.08
TIPS for refractory ascites: a 6-year single-center experience with expanded polytetrafluoroethylene-covered stent-grafts. AJR Am J Roentgenol (2015) 1.99
Effect of zolpidem on the sleep arousal response to nocturnal esophageal acid exposure. Clin Gastroenterol Hepatol (2009) 1.90
Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. J Nucl Med Technol (2008) 1.90
Seizure-related motor vehicle crashes in Arizona before and after reducing the driving restriction from 12 to 3 months. Mayo Clin Proc (2003) 1.80
Botulinum toxin A for the treatment of delayed gastric emptying. Am J Gastroenterol (2007) 1.78
Investigation of colonic and whole-gut transit with wireless motility capsule and radiopaque markers in constipation. Clin Gastroenterol Hepatol (2009) 1.73
Chronic idiopathic constipation: more than a simple colonic transit disorder. J Clin Gastroenterol (2012) 1.69
Brain stimulation for epilepsy. Lancet Neurol (2004) 1.69
Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus. Liver Transpl (2008) 1.68
Barrett's esophagus and achalasia. J Clin Gastroenterol (2002) 1.61
Survival and risk of recidivism in methadone-dependent patients undergoing liver transplantation. Am J Transplant (2003) 1.60
Electrical stimulation of the anterior nucleus of the thalamus for the treatment of intractable epilepsy. Epilepsia (2004) 1.58
Do stool form and frequency correlate with whole-gut and colonic transit? Results from a multicenter study in constipated individuals and healthy controls. Am J Gastroenterol (2009) 1.54
Use of a high caloric liquid meal as an alternative to a solid meal for gastric emptying scintigraphy. Dig Dis Sci (2013) 1.52
Wireless capsule motility: comparison of the SmartPill GI monitoring system with scintigraphy for measuring whole gut transit. Dig Dis Sci (2009) 1.50
Small intestinal bacterial overgrowth in gastroparesis. Dig Dis Sci (2012) 1.49
Sincalide-stimulated cholescintigraphy: a multicenter investigation to determine optimal infusion methodology and gallbladder ejection fraction normal values. J Nucl Med (2010) 1.48
Impact of chronic conditions on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis (2006) 1.47
Gastroparesis-related hospitalizations in the United States: trends, characteristics, and outcomes, 1995-2004. Am J Gastroenterol (2007) 1.45
De novo hepatocellular carcinoma occurring in a transplanted liver: case report and review of the literature. Dig Dis Sci (2006) 1.45
A randomized comparison of sirolimus-eluting versus bare metal stents in the treatment of diabetic patients with native coronary artery lesions: the DECODE study. Catheter Cardiovasc Interv (2008) 1.44
Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy. Liver Int (2013) 1.43
Egg labeling methods for gastric emptying scintigraphy are not equivalent in producing a stable solid meal. J Nucl Med (2007) 1.42
Persistent nausea and abdominal pain in a patient with delayed gastric emptying. Clin Gastroenterol Hepatol (2008) 1.41
Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis. Eur J Gastroenterol Hepatol (2014) 1.40
A blinded pilot study of artwork in a comprehensive epilepsy center population. Epilepsy Behav (2005) 1.39
Gastric neuromuscular pathology in gastroparesis: analysis of full-thickness antral biopsies. Dig Dis Sci (2010) 1.31
American Gastroenterological Association medical position statement: diagnosis and treatment of gastroparesis. Gastroenterology (2004) 1.30
Predictive factors for clinical improvement with Enterra gastric electric stimulation treatment for refractory gastroparesis. Dig Dis Sci (2007) 1.28
Psychological dysfunction is associated with symptom severity but not disease etiology or degree of gastric retention in patients with gastroparesis. Am J Gastroenterol (2010) 1.24
An audit of endoscopic complications in adult eosinophilic esophagitis. Clin Gastroenterol Hepatol (2007) 1.23
Ultrastructural differences between diabetic and idiopathic gastroparesis. J Cell Mol Med (2012) 1.23
Measurement of gastrointestinal transit. Dig Dis Sci (2005) 1.20
Closure of a nonhealing gastrocutaneous fistula using an endoscopic clip. South Med J (2007) 1.20
Altered expression of Ano1 variants in human diabetic gastroparesis. J Biol Chem (2011) 1.19
Detection of JC virus DNA sequences and expression of viral T antigen and agnoprotein in esophageal carcinoma. Cancer (2005) 1.15
A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients. Liver Transpl (2005) 1.13
Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis. Gastrointest Endosc (2005) 1.11
Early and late outcome of cardiac surgery in patients with liver cirrhosis. Liver Transpl (2007) 1.08
Long-term safety and effectiveness of lubiprostone, a chloride channel (ClC-2) activator, in patients with chronic idiopathic constipation. Dig Dis Sci (2011) 1.06
Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response. Hepatology (2014) 1.05
Simultaneous assessment of gastric accommodation and emptying: studies with liquid and solid meals. J Nucl Med (2004) 1.04
Heightened colon motor activity measured by a wireless capsule in patients with constipation: relation to colon transit and IBS. Am J Physiol Gastrointest Liver Physiol (2009) 1.03
Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Clin Gastroenterol Hepatol (2007) 1.03
Detection of seizure-like movements using a wrist accelerometer. Epilepsy Behav (2011) 1.03
Functional significance of the ipsilateral hemisphere during movement of the affected hand after stroke. Exp Neurol (2004) 1.03
Gastroparesis after combined heart and lung transplantation. J Clin Gastroenterol (2002) 1.01
Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon. Gastroenterology (2012) 1.01
Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle. Am J Gastroenterol (2002) 1.00
Achalasia presenting after operative and nonoperative trauma. Dig Dis Sci (2005) 1.00
Eosinophilic esophagitis presenting as spontaneous esophageal rupture (Boerhaave's syndrome). Clin Gastroenterol Hepatol (2006) 0.98
Conversion disorder. Am J Psychiatry (2006) 0.98
Peer-reviewed publication: a view from inside. Epilepsia (2004) 0.98
Comparison of a salivary/sputum pepsin assay with 24-hour esophageal pH monitoring for detection of gastric reflux into the proximal esophagus, oropharynx, and lung. Dig Dis Sci (2003) 0.98
A qualitative and quantitative angiographic analysis of stent fracture late following sirolimus-eluting stent implantation. Am J Cardiol (2009) 0.97
Inhibitory effects of botulinum toxin on pyloric and antral smooth muscle. Am J Physiol Gastrointest Liver Physiol (2003) 0.96
Abdominal pain is a frequent symptom of gastroparesis. Clin Gastroenterol Hepatol (2010) 0.96
Symptoms of gastroparesis: use of the gastroparesis cardinal symptom index in symptomatic patients referred for gastric emptying scintigraphy. Digestion (2008) 0.96
Focally injected adenosine prevents seizures in the rat. Exp Neurol (2004) 0.95
Regional postprandial differences in pH within the stomach and gastroesophageal junction. Dig Dis Sci (2005) 0.95
Gastric emptying of solids and liquids for evaluation for gastroparesis. Dig Dis Sci (2011) 0.95
Outcome analysis of cirrhotic patients undergoing chest tube placement. Chest (2004) 0.94
Immunoglobulins from scleroderma patients inhibit the muscarinic receptor activation in internal anal sphincter smooth muscle cells. Am J Physiol Gastrointest Liver Physiol (2009) 0.94
Simultaneous measurement of gastric emptying with a simple muffin meal using [13C]octanoate breath test and scintigraphy in normal subjects and patients with dyspeptic symptoms. Dig Dis Sci (2002) 0.94
Multichannel electrogastrography (EGG) in normal subjects: a multicenter study. Dig Dis Sci (2004) 0.93
Update on gastrointestinal scintigraphy. Semin Nucl Med (2006) 0.93
Bloating in gastroparesis: severity, impact, and associated factors. Am J Gastroenterol (2011) 0.93
The importance of the dominant hemisphere in the organization of bimanual movements. Hum Brain Mapp (2003) 0.93
Decreased length of stay and cumulative hospitalized days despite increased patient admissions and readmissions in an area of urban poverty. J Gen Intern Med (2010) 0.92
Effect of altering gastric emptying on postprandial plasma glucose concentrations following a physiologic meal in type-II diabetic patients. Dig Dis Sci (2003) 0.91
Influenza vaccination in orthotopic liver transplant recipients: absence of post administration ALT elevation. Am J Transplant (2004) 0.91
An online diary for tracking epilepsy. Epilepsy Behav (2011) 0.91
Gastric emptying scintigraphy: is four hours necessary? J Clin Gastroenterol (2012) 0.91
Abnormal ghrelin and pancreatic polypeptide responses in gastroparesis. Dig Dis Sci (2006) 0.90
Plasma cell hepatitis in hepatitis C virus patients post-liver transplantation: case-control study showing poor outcome and predictive features in the liver explant. Liver Transpl (2009) 0.90
Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation. Liver Transpl (2006) 0.90
Cooling abolishes neuronal network synchronization in rat hippocampal slices. Epilepsia (2002) 0.90